The U.S. Food and Drug Administration today approved thefirst generic versions of Celebrex (celecoxib) capsules, a treatment forrheumatoid arthritis, osteoarthritis, short-term (acute) pain, and otherconditions.

“It is important for patients to have access to affordabletreatment options for chronic conditions,” said Janet Woodcock, M.D., directorof the FDA’s Center for Drug Evaluation and Research. “Health care professionalsand patients can be assured that these FDA-approved generic drugs have met ourrigorous approval standards.”

Generic Celebrex 200mg is a Non-Steroidal Anti-Inflammatory Drug (NSAID).All NSAIDs have a Boxed Warning in their prescribing information (label) to alert health care professionals and patients about the risk of heart attack or stroke that can lead to death. This chance increases for people with heart disease or risk factors for it, such as high blood pressure, or taking NSAIDs for longperiods of time. The Boxed Warning also highlights the risk of serious

Information about the availability of Generic Celebrex 200mg can be obtained from the companies.